Homepage
Latest News and Highlights from Mayo Clinic's Center for Regenerative Biotherapeutics
Nathan Staff, M.D, Ph.D., and his team are researching the potential of cell-based therapies to promote ...
This story was previously published in Mayo Clinic Magazine. Allan B. Dietz, Ph.D., never intended to be a scientist. His plan was to be a farmer, just like his father, grandfather and all the other Dietzes he knew. "I was going to be a farmer at first. Then I was going to be a veterinarian because that's what farm kids who like science did," Dr. Dietz says.
Patricia Devaux, Ph.D., is testing a new technology to reprogram human blood cells to go back to a state from which they can then ...
It was during a morning commute when Wendy Himley noticed her left foot was swollen. She wondered ...
The Center for Regenerative Medicine has announced the selection of five new directors on its leadership team. The leaders will fill the positions for associate directors in ...
When a baby’s lungs are not adequately developed at birth, severe complications and even death can result. Rodrigo Ruano, M.D., Ph.D., a recent Regenerative Medicine Minnesota ...
A heart attack occurs when the flow of blood to the heart is blocked, most often by a build-up of fat, cholesterol and other substances, which form a plaque in the arteries that feed the heart (coronary arteries). The interrupted blood flow can damage or destroy part of the heart muscle. Satsuki Yamada, M.D., Ph.D., a recent recipient of a Regenerative Medicine Minnesota Translational Research Grant, is investigating the use of patient’s own stem cells as a new therapy to help reestablish and maintain a synchronized pumping motion in the infarcted heart.
There’s a ...
As medical treatments and technologies advance at an unparalleled pace — particularly in the field of regenerative medicine — there is a need to develop new scientifically-based standards and metrics to assess the safety, efficacy, and quality of diagnostic and therapeutic products. Development of techniques and measurements to assess these characteristics of clinical products is known as “regulatory science.”